Category Archives: Globe Newswire

Global Times: China helps weave a greener Asia-Pacific by turning its development gains into shared opportunities

Global Times: China helps weave a greener Asia-Pacific by turning its development gains into shared opportunities

BEIJING, Nov. 18, 2026 (GLOBE NEWSWIRE) — The 33rd Asia-Pacific Economic Cooperation (APEC) Economic Leaders’ Meeting is being held in Shenzhen from November 18 to 19.  This year marks the first time in 12 years that China is hosting the APEC meeting. “We are ready to work with all other parties to forge ahead with […]

JOYY Reports Third Quarter 2026 Unaudited Financial Results

JOYY Reports Third Quarter 2026 Unaudited Financial Results

SINGAPORE, Nov. 19, 2026 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced its unaudited financial results for the third quarter of 2026. Third Quarter 2026 Financial Highlights1 Net revenues were US$624.6 million, an increase of 15.6% from US$540.2 million in the corresponding period of 2025, and […]

Seventy Years of Diplomatic Ties, Masks as a New Language: Colorful Guizhou Launches China–Egypt Dialogue of Civilizations Through Theatrical Masks

Seventy Years of Diplomatic Ties, Masks as a New Language: Colorful Guizhou Launches China–Egypt Dialogue of Civilizations Through Theatrical Masks

CAIRO, Nov. 18, 2026 (GLOBE NEWSWIRE) — On November 17, “Charm of Masks: Dialogue of Civilizations,” an event held as part of the series for the 2026 “China-Africa Year of People-to-People Exchanges,” took place in Cairo, Egypt. Co-hosted by Guizhou Radio and Television Station and the China Cultural Center in Cairo, and organized by the […]

HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

— A novel EGFR-directed ATTC with a potent pan-KRAS payload designed to overcome resistance and systemic toxicity associated with EGFR/KRAS inhibition — — Broad-spectrum activity across multiple KRAS mutations, combining inhibition of both ON and OFF states to intercept adaptive resistance — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) […]

Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company

Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company

Teva’s Pivot to Growth Strategy, R&D priorities, and expectations remain unchanged; Company initiates search for successor TEL AVIV, Israel and PARSIPPANY, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer, has decided to leave […]

REEcycle Holdings, Inc. and Hall Chadwick Acquisition Corp. Announce Additional $15.0 Million PIPE Commitments from Leading Institutional Stockholders

REEcycle Holdings, Inc. and Hall Chadwick Acquisition Corp. Announce Additional $15.0 Million PIPE Commitments from Leading Institutional Stockholders

Two leading global institutional investors, including a top-five asset manager by assets under management, make PIPE raise commitments. Committed PIPE now totals $17.1 million ahead of the proposed Nasdaq listing DUNCAN, Okla., Nov. 18, 2026 (GLOBE NEWSWIRE) — REEcycle Holdings, Inc. (“REEcycle”), a U.S.-based rare earth recycling company, and Hall Chadwick Acquisition Corp. (Nasdaq: HCAC, […]

InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent System

InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent System

– First commercial cases mark return of the CGuard Prime platform to the U.S. market – – Milestone expands commercial application of proprietary MicroNet™ Mesh-covered CGuard Prime stent platform to include transcarotid artery revascularization (“TCAR”) procedures – MIAMI, Nov. 18, 2026 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the […]

MEDIROM Announces Receipt of Nasdaq Delisting Notice, Filing of Annual Report and Submission of Hearing Request

MEDIROM Announces Receipt of Nasdaq Delisting Notice, Filing of Annual Report and Submission of Hearing Request

TOKYO, Nov. 18, 2026 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Nasdaq: MRM) (the “Company”) today announced that on November 13, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) because the Company had not filed its Annual Report on Form 20-F for the year […]

Cyabra Announces 30-to-1 Reverse Stock Split

Cyabra Announces 30-to-1 Reverse Stock Split

New York, NY, Nov. 18, 2026 (GLOBE NEWSWIRE) — Cyabra, Inc. (Nasdaq: CYAB) (“Cyabra” or the “Company”), an artificial intelligence (“AI”)-powered narrative intelligence company that helps governments and enterprises detect coordinated manipulation and protect digital trust, today announced that a reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding common stock, […]

CORRECTION — ProLogium and TDAC Announce Prospective Investments of $135 Million 

CORRECTION -- ProLogium and TDAC Announce Prospective Investments of $135 Million 

In a release issued under the headline “ProLogium and TDAC Announce Prospective Investments of $85 Million” today, November 18th by ProLogium Holding Inc., please note that the investments amount should have read $135 Million and not $85 Million. The corrected release follows:  Non-binding term sheets signed for up to $135 million of investment Existing and strategic investors […]